MeSH tree: D13
A major clinical trial involving 410 people with early Parkinson's disease has found no clinical benefit from nicotinamide riboside (NR), a compound that increases cellular levels of nicotinamide adenine dinucleotide (NAD). ...
4 hours ago
0
0
Mayo Clinic researchers report encouraging early results from an experimental therapy targeting the genetic cause of a rare form of amyotrophic lateral sclerosis, or ALS.
Oct 2, 2026
0
18
In a study published in Cancer Discovery, cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells.
Sep 29, 2026
0
13
Scientists at Queen Mary University of London have found a way to overcome cells' natural defenses against self-amplifying mRNA vaccines, allowing the cells to produce significantly more of the target protein. The findings ...
Sep 28, 2026
2
110
Chronic hepatitis B is a long-lasting condition caused by the hepatitis B virus (HBV) that affects about 240 million people worldwide. Most people infected show no symptoms for years, but when symptoms do appear, they can ...
A blood test that aims to catch more than 50 types of cancer before symptoms appear narrowly won the backing of U.S. Food and Drug Administration (FDA) advisers Wednesday, even as several doubted it works.
Sep 24, 2026
0
9
Researchers at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues have discovered that a type of rogue DNA found in aggressive cancers has a hidden structural weakness—and that blocking a single repair protein ...
Sep 23, 2026
0
8
A new study published in Nature has established the foundational landscape of tumor evolution in bladder cancer and differences among cancer subtypes, which could point toward better diagnosis and treatment of the disease.
Sep 16, 2026
0
2
The heart undergoes major changes during the first weeks of life. Researchers at Karolinska Institutet have now shown that a previously unknown metabolic vulnerability in mitochondria can disrupt heart development. The study, ...
Sep 14, 2026
0
5
The investigational combination of pumitamig and elfetabart drozuntecan (elfe-D) demonstrated a manageable safety profile and encouraging early antitumor activity in patients with small cell lung cancer (SCLC), according ...
Sep 12, 2026
0
21
